Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Latha B. Pathangey"'
Autor:
Latha B. Pathangey, Vani Lakshminarayanan, Vera J. Suman, Barbara A. Pockaj, Pinku Mukherjee, Sandra J. Gendler
Publikováno v:
Biomolecules, Vol 6, Iss 3, p 31 (2016)
Cancer vaccines have often failed to live up to their promise, although recent results with checkpoint inhibitors are reviving hopes that they will soon fulfill their promise. Although mutation-specific vaccines are under development, there is still
Externí odkaz:
https://doaj.org/article/f03caf596dbf42ac9686832a116a0c2c
Autor:
Sandra J. Gendler, Latha B. Pathangey, P. Leif Bergsagel, Trupti Vardam-Kaur, Daniel J. McCormick, Peter A. Cohen
Publikováno v:
Oncotarget. 12:2051-2067
Multiple Myeloma (MM) patients suffer disease relapse due to the development of therapeutic resistance. Increasing evidence suggests that immunotherapeutic strategies can provide durable responses. Here we evaluate the possibility of adoptive cell tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42f0ab23d06f066853ab1b1e97871784
https://doi.org/10.18632/oncotarget.28067
https://doi.org/10.18632/oncotarget.28067
Autor:
Trupti, Vardam-Kaur, Latha B, Pathangey, Daniel J, McCormick, P Leif, Bergsagel, Peter A, Cohen, Sandra J, Gendler
Publikováno v:
Oncotarget
Multiple Myeloma (MM) patients suffer disease relapse due to the development of therapeutic resistance. Increasing evidence suggests that immunotherapeutic strategies can provide durable responses. Here we evaluate the possibility of adoptive cell tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f2a78503dc8a15e1debc94c231ba9180
https://pubmed.ncbi.nlm.nih.gov/34611479
https://pubmed.ncbi.nlm.nih.gov/34611479
Autor:
Vera J. Suman, Latha B. Pathangey, Vani Lakshminarayanan, Barbara A. Pockaj, Sandra J. Gendler, Pinku Mukherjee
Publikováno v:
Biomolecules; Volume 6; Issue 3; Pages: 31
Biomolecules
Biomolecules, Vol 6, Iss 3, p 31 (2016)
Biomolecules
Biomolecules, Vol 6, Iss 3, p 31 (2016)
Cancer vaccines have often failed to live up to their promise, although recent results with checkpoint inhibitors are reviving hopes that they will soon fulfill their promise. Although mutation-specific vaccines are under development, there is still
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9b41de5fac566cd96507277130838eb
Autor:
Amanda Maree Walmsley, M. Lucrecia Alvarez, Sandra J. Gendler, Hugh S. Mason, Julia Pinkhasov, Pinku Mukherjee, Teresa L. Tinder, Latha B. Pathangey
Publikováno v:
Cancer Immunology, Immunotherapy. 59:1801-1811
Since epithelial mucin 1 (MUC1) is associated with several adenocarcinomas at the mucosal sites, it is pertinent to test the efficacy of a mucosally targeted vaccine formulation. The B subunit of the Vibrio cholerae cholera toxin (CTB) has great pote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82d3f96ec682e1c058ceba96b6cd5aa5
https://doi.org/10.1007/s00262-010-0906-1
https://doi.org/10.1007/s00262-010-0906-1
Autor:
J.B. Bradley, Emmanuel T. Akporiaye, Pinku Mukherjee, Latha B. Pathangey, Gargi D. Basu, Sandra J. Gendler, Teresa L. Tinder
Publikováno v:
Vaccine. 25:1607-1618
A MUC1-based vaccine was used in a preclinical model of colon cancer. The trial was conducted in a MUC1-tolerant immune competent host injected with MC38 colon cancer cells expressing MUC1. The vaccine included: MHC class I-restricted MUC1 peptides,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0ff6c6178a2b356ec3312553a9557d5
https://doi.org/10.1016/j.vaccine.2006.11.007
https://doi.org/10.1016/j.vaccine.2006.11.007
Autor:
Gargi D. Basu, Latha B. Pathangey, Teresa L. Tinder, Michelle LaGioia, Sandra J. Gendler, Pinku Mukherjee
Publikováno v:
Molecular Cancer Research. 2:632-642
Cyclooxygenase-2 (COX-2) inhibitors are rapidly emerging as a new generation of therapeutic drug in combination with chemotherapy or radiation therapy for the treatment of cancer. The mechanisms underlying its antitumor effects are not fully understo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7db7c498d40823570287ae028f9cfcd4
https://doi.org/10.1158/1541-7786.632.2.11
https://doi.org/10.1158/1541-7786.632.2.11
Autor:
Jose L. Hernandez, Barbara A. Pockaj, Richard Gray, Gargi D. Basu, Latha B. Pathangey, Sandra J. Gendler, Pinku Mukherjee
Publikováno v:
Annals of Surgical Oncology. 11:328-339
In several neoplastic diseases, including breast cancer, immunosuppression correlates with disease stage, progression, and outcome. Thus, thorough analysis of immune parameters in breast cancer patients may be beneficial in designing effective antica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::589a49c488b9cc2927227a7e7c346a46
https://doi.org/10.1245/aso.2004.05.027
https://doi.org/10.1245/aso.2004.05.027
Autor:
James H. Finke, Patricia Rayman, Judy M. Bradley, Jessica E. Gorman, Walter J. Storkus, Soroya Zorro-Manrique, Peter A. Cohen, Anna Lucia Dominguez, Brian I. Rini, Sandra J. Gendler, Dustin B. McCurry, Latha B. Pathangey, Christopher D. Spencer, Jennifer S. Ko
Publikováno v:
Immunological investigations. 41(6-7)
The receptor tyrosine kinase inhibitor, sunitinib, is astonishingly effective in its capacity to reduce MDSCs in peripheral tissues such as blood (human) and spleen (mouse), restoring responsiveness of bystander T lymphocytes to TcR stimulation. Suni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4eef827dd142a96b56f387232ad167d4
https://pubmed.ncbi.nlm.nih.gov/23017141
https://pubmed.ncbi.nlm.nih.gov/23017141
Autor:
Geert-Jan Boons, Cathy S. Madsen, Sandra J. Gendler, Judy M. Bradley, Vani Lakshminarayanan, Latha B. Pathangey, Margreet A. Wolfert, Pamela Thompson, Therese Buskas, Peter A. Cohen
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 109(1)
The mucin MUC1 is typically aberrantly glycosylated by epithelial cancer cells manifested by truncated O -linked saccharides. The resultant glycopeptide epitopes can bind cell surface major histocompatibility complex (MHC) molecules and are susceptib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::599bdd7408fccb9c144acb5491d48608
https://pubmed.ncbi.nlm.nih.gov/22171012
https://pubmed.ncbi.nlm.nih.gov/22171012